Effect of Postnatal Epigallocatechin-Gallate Treatment on Cardiac Function in Mice Prenatally Exposed to Alcohol
Authors:
- Vicente Andreu-FernándezVicente Andreu-Fernández
- Mariona Serra-DelgadoMSMariona Serra-Delgado
- Laura Almeida-ToledanoLALaura Almeida-Toledano
- Àgueda García-MeseguerÀGÀgueda García-Meseguer
- Melina VieirosMVMelina Vieiros
- Anna Ramos-TrigueroARAnna Ramos-Triguero
- Concha Muñoz-LozanoCMConcha Muñoz-Lozano
- Elisabet Navarro-TapiaENElisabet Navarro-Tapia
- Leopoldo MartínezLMLeopoldo Martínez
- Óscar García-AlgarÓscar García-Algar
- María D. Gómez-RoigMGMaría D. Gómez-Roig
Open Access
- 9 May 2023
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 12 (5) , 1067
Abstract
Prenatal alcohol exposure affects the cardiovascular health of the offspring. Epigallocatechin-3-gallate (EGCG) may be a protective agent against it, but no data are available regarding its impact on cardiac dysfunction. We investigated the presence of cardiac alterations in mice prenatally exposed to alcohol and the effect of postnatal EGCG treatment on cardiac function and related biochemical pathways. C57BL/6J pregnant mice received 1.5 g/kg/day (Mediterranean pattern), 4.5 g/kg/day (binge pattern) of ethanol, or maltodextrin until Day 19 of pregnancy. Post-delivery, treatment groups received EGCG-supplemented water. At post-natal Day 60, functional echocardiographies were performed. Heart biomarkers of apoptosis, oxidative stress, and cardiac damage were analyzed by Western blot. BNP and Hif1α increased and Nrf2 decreased in mice prenatally exposed to the Mediterranean alcohol pattern. Bcl-2 was downregulated in the binge PAE drinking pattern. Troponin I, glutathione peroxidase, and Bax increased in both ethanol exposure patterns. Prenatal alcohol exposure led to cardiac dysfunction in exposed mice, evidenced by a reduced ejection fraction, left ventricle posterior wall thickness at diastole, and Tei index. EGCG postnatal therapy restored the physiological levels of these biomarkers and improved cardiac dysfunction. These findings suggest that postnatal EGCG treatment attenuates the cardiac damage caused by prenatal alcohol exposure in the offspring.Keywords
Funding Information
- Instituto de Salud Carlos III (RD16/0022/0002, PI15/01179, PI16/00566, PI19/01853, RD21/0012/0003)
- FEDER and Instituto de Salud Carlos III (RD16/0022/0002, PI15/01179, PI16/00566, PI19/01853, RD21/0012/0003)
- Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin (RD16/0022/0002, PI15/01179, PI16/00566, PI19/01853, RD21/0012/0003)
This publication has 96 references indexed in Scilit:
- EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expressionVascular Cell, 2013
- The expression of antioxidant enzymes in a mouse model of fetal alcohol syndromeAmerican Journal of Obstetrics and Gynecology, 2012
- Guidelines for pregnancy: What's an acceptable risk, and how is the evidence (finally) shaping up?Drug and Alcohol Review, 2011
- Echocardiography in MiceCurrent Protocols in Mouse Biology, 2011
- The Preventive Effect of Oral EGCG in a Fetal Alcohol Spectrum Disorder Mouse ModelAlcohol, Clinical and Experimental Research, 2010
- Effects of alcohol and smoking during pregnancy on infant autonomic controlDevelopmental Psychobiology, 2009
- Nrf2-Mediated Transcriptional Induction of Antioxidant Response in Mouse Embryos Exposed to Ethanol in vivo : Implications for the Prevention of Fetal Alcohol Spectrum DisordersAntioxidants & Redox Signaling, 2008
- Antioxidants prevent ethanol-associated apoptosis in fetal rhombencephalic neuronsBrain Research, 2008
- Congenital Heart Defects and Fetal Alcohol Spectrum DisordersCongenital Heart Disease, 2007
- Biochemistry and Molecular BiologyThe Serials Librarian, 1996